Home > National Drug Code (NDC) > ATACAND HCT

ATACAND HCT - 0186-0162-28 - (Candesartan cilexetil and Hydrochlorothiazide)

Alphabetical Index


Drug Information of ATACAND HCT

Product NDC: 0186-0162
Proprietary Name: ATACAND HCT
Non Proprietary Name: Candesartan cilexetil and Hydrochlorothiazide
Active Ingredient(s): 16; 12.5    mg/1; mg/1 & nbsp;   Candesartan cilexetil and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of ATACAND HCT

Product NDC: 0186-0162
Labeler Name: AstraZeneca LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021093
Marketing Category: NDA
Start Marketing Date: 20000928

Package Information of ATACAND HCT

Package NDC: 0186-0162-28
Package Description: 100 TABLET in 1 CARTON (0186-0162-28)

NDC Information of ATACAND HCT

NDC Code 0186-0162-28
Proprietary Name ATACAND HCT
Package Description 100 TABLET in 1 CARTON (0186-0162-28)
Product NDC 0186-0162
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Candesartan cilexetil and Hydrochlorothiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20000928
Marketing Category Name NDA
Labeler Name AstraZeneca LP
Substance Name CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Strength Number 16; 12.5
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of ATACAND HCT


General Information